592 related articles for article (PubMed ID: 21644073)
1. [Evaluation of serum IgG, IgA and IgM levels as indicators of hepatic fibrosis in patients with chronic hepatitis C infection].
Ortarık Z; Toyran A; Sen S; Mart Kömürcü SZ; Güvener E
Mikrobiyol Bul; 2011 Apr; 45(2):296-305. PubMed ID: 21644073
[TBL] [Abstract][Full Text] [Related]
2. Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection.
Watt K; Uhanova J; Gong Y; Kaita K; Doucette K; Pettigrew N; Minuk GY
J Viral Hepat; 2004 May; 11(3):251-6. PubMed ID: 15117327
[TBL] [Abstract][Full Text] [Related]
3. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
[TBL] [Abstract][Full Text] [Related]
4. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
Stránský J; Ryzlová M; Striteský J; Horák J
Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients.
Vasei M; Monabbati A; Alizadeh-Naeeni M; Houshmand S; Azarpira N; Lankarani KB; Mosallaee M; Taghavi Sa; Geramizadeh B; Saberi-Firouzi M; Imaniyeh MH
Hepatogastroenterology; 2008; 55(84):1066-70. PubMed ID: 18705329
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of IgM anti-HCV determination in chronic hepatitis C].
Stránský J; Krtek V; Honzáková E; Vandasová J; Mand'áková Z; Kyncl J; Nĕmecek V
Cas Lek Cesk; 1996 Apr; 135(7):215-9. PubMed ID: 8681370
[TBL] [Abstract][Full Text] [Related]
9. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
10. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
11. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
12. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
[TBL] [Abstract][Full Text] [Related]
13. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of anticardiolipin antibodies in chronic hepatitis B infection together with total anti-delta positivity].
Meşe S; Ozekinci T; Atmaca S; Arikan E; Akin D
Mikrobiyol Bul; 2008 Jul; 42(3):483-7. PubMed ID: 18822893
[TBL] [Abstract][Full Text] [Related]
15. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
Sebastiani G; Vario A; Guido M; Alberti A
J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
[TBL] [Abstract][Full Text] [Related]
16. HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies.
el-Gohary A; Hosny AM; Fawaz N; Heiba A; Abdalla E; Kawano F; Kiyokawa T
Jpn J Infect Dis; 1999 Jun; 52(3):113-6. PubMed ID: 10507990
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases 2 and 9 are markers of inflammation but not of the degree of fibrosis in chronic hepatitis C.
Reif S; Somech R; Brazovski E; Reich R; Belson A; Konikoff FM; Kessler A
Digestion; 2005; 71(2):124-30. PubMed ID: 15785038
[TBL] [Abstract][Full Text] [Related]
18. [A dynamic observation on serum cytokine and immunoglobulin (IgG, IgA, IgM) in patients with esophageal cancer].
Tang RG; Yuan XH; Tang TT; Tang XQ; Hang YQ; Qin HJ; Chen HM; Fang WZ; Long XK
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():35-8. PubMed ID: 17767855
[TBL] [Abstract][Full Text] [Related]
19. Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase-2 in patients with HCV-related chronic hepatitis. Relationship to histological features.
Bruno CM; Valenti M; Bertino G; Ardiri A; Consolo M; Mazzarino CM; Amoroso A; Neri S
Panminerva Med; 2009 Dec; 51(4):191-6. PubMed ID: 20195229
[TBL] [Abstract][Full Text] [Related]
20. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
